Immunization Against Bacterial Diseases of the Intestine

The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome

1991 • 1,859 citations

Escherichia coli that Cause Diarrhea: Enterotoxigenic, Enteropathogenic, Enteroinvasive, Enterohemorrhagic, and Enteroadherent

1987 • 1,279 citations

Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

1999 • 1,261 citations

Cholera

1995 • 1,189 citations

A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.

1990 • 1,146 citations

A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence.

1989 • 943 citations

Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.

1988 • 703 citations

An Inducible Bundle-Forming Pilus of Enteropathogenic Escherichia coli

1991 • 610 citations

Inoculum Size in Shigellosis and Implications for Expected Mode of Transmission

1989 • 590 citations

New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development

1983 • 573 citations

Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up

1990 • 497 citations

Colonization factors of human enterotoxigenic Escherichia coli (ETEC)

1996 • 463 citations

Typhoid fever in children aged less than 5 years

1999 • 450 citations

Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine in Developing Countries: Review

1991 • 438 citations

Shiga Toxin: Biochemistry, Genetics, Mode of Action, and Role in Pathogenesis

1992 • 423 citations

THE INTERNATIONAL CONFERENCE ON HARMONIZATION GOOD CLINICAL PRACTICE GUIDELINE

1999 • 408 citations

Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages

1990 • 399 citations

Multidrug-Resistant Salmonella typhi: A Worldwide Epidemic

1997 • 399 citations

Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella Typhi

1987 • 385 citations

Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae 0139 synonym Bengal

1993 • 358 citations

LARGE-SCALE FIELD TRIAL OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULE FORMULATION

1987 • 355 citations

Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field Trial

1988 • 342 citations

A Controlled Field Trial of Live Salmonella typhi Strain Ty 21a Oral Vaccine Against Typhoid: Three-Year Results

1982 • 326 citations

SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR

1988 • 318 citations

Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994?

1995 • 312 citations

PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER

1987 • 308 citations

Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli

1997 • 306 citations

Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis.

1994 • 289 citations

LONGITUDINAL STUDIES OF INFECTIOUS DISEASES AND PHYSICAL GROWTH OF CHILDREN IN RURAL BANGLADESH

1982 • 289 citations

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

1995 • 288 citations

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1999 • 283 citations

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine

1991 • 278 citations

Polysaccharide-Protein Conjugates: A New Generation of Vaccines

1990 • 275 citations

PREDISPOSITION FOR CHOLERA OF INDIVIDUALS WITH O BLOOD GROUP POSSIBLE EVOLUTIONARY SIGNIFICANCE

1985 • 272 citations

phoP/phoQ-Deleted Salmonella typhi (Ty800) Is a Safe and Immunogenic Single Dose Typhoid Fever Vaccine in Volunteers

1996 • 268 citations

Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity

1998 • 264 citations

M cells as ports of entry for enteroinvasive pathogens: Mechanisms of interaction, consequences for the disease process

1999 • 263 citations

New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

1983 • 263 citations

Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1

1988 • 262 citations

Diarrheal Disease during Operation Desert Shield

1991 • 259 citations

Duration of Infection-Derived Immunity to Cholera

1981 • 255 citations

Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans

1997 • 248 citations

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

1997 • 247 citations

Reexamination of the Protective Role of the Capsular Polysaccharide (Vi antigen) of Salmonella typhi

1984 • 246 citations

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine

1991 • 237 citations

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

2000 • 230 citations

Vaccination against Shigellosis with Attenuated Shigella flexneri 2a Strain SC602

1999 • 228 citations

Vaccination against typhoid fever: present status.

1994 • 224 citations

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine

1999 • 224 citations

Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers

1992 • 219 citations

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization

1996 • 219 citations

TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTS

1987 • 214 citations

Epidemiologic Patterns of Acute Diarrhea and Endemic Shigella Infections in Children in a Poor Periurban Setting in Santiago, Chile

1991 • 213 citations

Efficacy Of A Quadrivalent Rhesus Rotavirus-Based Human Rotavirus Vaccine Aimed At Preventing Severe Rotavirus Diarrhea In Infants And Young Children

1996 • 211 citations

Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection

1972 • 207 citations

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

1990 • 202 citations

Prevalence of Toxin Types and Colonization Factors in Enterotoxigenic Escherichia coli Isolated during a 2-Year Period from Diarrheal Patients in Bangladesh

2000 • 200 citations

Precise Estimation of the Numbers of Chronic Carriers of Salmonella typhi in Santiago, Chile, an Endemic Area

1982 • 199 citations

Seroepidemiological Studies of EI Tor Cholera in Bangladesh: Association of Serum Antibody Levels with Protection

1985 • 193 citations

Construction of genetically defined double aro mutants of Salmonella typhi

1991 • 191 citations

Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits

1994 • 191 citations

Progress in Vaccines Against Typhoid Fever

1989 • 182 citations

Hypothesis for Vaccine Development: Protective Immunity to Enteric Diseases Caused by Nontyphoidal Salmonellae and Shigellae May Be Conferred by Serum IgG Antibodies to the O-Specific Polysaccharide of Their Lipopolysaccharides

1992 • 181 citations

Diagnostic Value of the Widal Test in Areas Endemic for Typhoid Fever *

1978 • 181 citations

Immunity of cholera in man: Relative role of antibacterial versus antitoxic immunity

1979 • 180 citations

Phase 2 Clinical Trial of AttenuatedSalmonella entericaSerovar Typhi Oral Live Vector Vaccine CVD 908-htrAin U.S. Volunteers

2000 • 180 citations

Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains

1995 • 179 citations

Pathophysiology of Salmonella diarrhea in the Rhesus monkey: Intestinal transport, morphological and bacteriological studies.

1974 • 178 citations

The RcsB–RcsC regulatory system of Salmonella typhi differentially modulates the expression of invasion proteins, flagellin and Vi antigen in response to osmolarity

1998 • 177 citations

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant

1998 • 172 citations

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1999 • 172 citations

Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

1999 • 165 citations

Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.

1989 • 161 citations

Cytokine Production Patterns And Lymphoproliferative Responses In Volunteers Orally Immunized With Attenuated Vaccine Strains Of Salmonella Typhi

1994 • 158 citations

Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis

1991 • 158 citations

Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model

1992 • 157 citations

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

1992 • 155 citations

Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro.

1995 • 155 citations

Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain

1992 • 148 citations

Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium

1990 • 146 citations

Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae 0139 vaccine prototype

1995 • 145 citations

Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease

1990 • 145 citations

Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgR

1992 • 142 citations

The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients.

1968 • 142 citations

Safety and Immunogenicity of Vi Conjugate Vaccines for Typhoid Fever in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam

1999 • 141 citations

Peru-15, an Improved Live Attenuated Oral Vaccine Candidate for Vibrio cholerae O1

1995 • 138 citations

Strategy for Cross-Protection amongShigella flexneriSerotypes

1999 • 136 citations

Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.

1987 • 135 citations

Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression

1994 • 128 citations

Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans.

1995 • 128 citations

Effect of Prior Infection with Virulent Shigella flexneri 2a on the Resistance of Monkeys to Subsequent Infection with Shigella sonnei

1991 • 127 citations

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines

1994 • 124 citations

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

1997 • 123 citations

Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine

1990 • 117 citations

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres

1994 • 117 citations

Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in Thailand

1992 • 116 citations

Multidrug-Resistant Typhoid in Children: Presentation and Clinical Features

1991 • 116 citations

Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels

1993 • 114 citations

Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG

1996 • 113 citations

Relation between structure and immunologic properties of the Vi capsular polysaccharide

1991 • 112 citations

Epidemic Shigella dysenteriae Type 1 in Burundi: Panresistance and Implications for Prevention

1994 • 111 citations

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity

1995 • 111 citations

Vi SEROLOGY IN DETECTION OF CHRONIC SALMONELLA TYPHI CARRIERS IN AN ENDEMIC AREA

1983 • 110 citations

Evolutionary origin of pathogenic determinants in enterotoxigenic Escherichia coli and Vibrio cholerae O1

1987 • 109 citations

Characterization of the rcsA and rcsB genes from Salmonella typhi: rcsB through tviA is involved in regulation of Vi antigen synthesis

1996 • 109 citations

Effect of Small Bowel Bacterial Overgrowth on the Immunogenicity of Single‐Dose Live Oral Cholera Vaccine CVD 103‐HgR

1999 • 108 citations

Role of the viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigen

1995 • 105 citations

Intestinal Immune Responses to an Inactivated Oral Enterotoxigenic Escherichia coli Vaccine and Associated Immunoglobulin A Responses in Blood

1998 • 105 citations

Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models

1993 • 104 citations

Optimism over vaccines administered via mucosal surfaces

1998 • 104 citations

Initial Clinical Studies of CVD 112 Vibrio cholerae O139 Live Oral Vaccine: Safety and Efficacy against Experimental Challenge

1995 • 103 citations

Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine

1996 • 102 citations

A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

1968 • 102 citations

RUBELLA VIRAEMIA AND ANTIBODY RESPONSES AFTER RUBELLA VACCINATION AND REIMMUNISATION

1981 • 99 citations

Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years

1984 • 99 citations

Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area.

1981 • 98 citations

Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.

1971 • 98 citations

Pathophysiology of Shigella Diarrhea in the Rhesus Monkey: Intestinal Transport, Morphological, and Bacteriological Studies

1975 • 95 citations

Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines.

1968 • 94 citations

Field Trial of Oral Cholera Vaccines in Bangladesh: Serum Vibriocidal and Antitoxic Antibodies as Markers of the Risk of Cholera

1991 • 93 citations

Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial.

1965 • 93 citations

Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors

1996 • 92 citations

Shigella flexneri 2a Strain CVD 1207, with Specific Deletions in virG , sen , set , and guaBA , Is Highly Attenuated in Humans

2000 • 91 citations

Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo.

1997 • 91 citations

Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial

1992 • 90 citations

Prevalence of Shigella Enterotoxin 1 among Shigella Clinical Isolates of Diverse Serotypes

1995 • 88 citations

Oral, Inactivated, Whole Cell EnterotoxigenicEscherichia coliplus Cholera Toxin B Subunit Vaccine: Results of the Initial Evaluation in Children

1999 • 88 citations

Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers

1996 • 88 citations

Virulence of B. typhosus and resistance to o antibody

1934 • 87 citations

The pathogenic and immunogenic activities ofSalmonella typhiin relation to its antigenic constituents

1951 • 86 citations

Safety, Immunogenicity, and Transmissibility of Single-Dose Live Oral Cholera Vaccine Strain CVD l03-HgR in 24- to 59-Month-Old Indonesian Children

1993 • 85 citations

Salmonella typhi infection in children younger than five years of age

1993 • 82 citations

Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection

1995 • 81 citations

Safety and Immunogenicity of an Oral, Killed EnterotoxigenicEscherichia coli‐Cholera Toxin B Subunit Vaccine in Egyptian Adults

1998 • 81 citations

Two‐Year Study of the Protective Efficacy of the Oral Whole Cell plus Recombinant B Subunit Cholera Vaccine in Peru

2000 • 79 citations

Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults

1990 • 79 citations

Genetically Detoxified Mutants of Heat-Labile Toxin from Escherichia coli Are Able To Act as Oral Adjuvants

1999 • 78 citations

Safety and Immunogenicity ofShigella sonneiandShigella flexneri2a O‐Specific Polysaccharide Conjugates in Children

1999 • 77 citations

Tropical Enteropathy (Environmental Enteropathy) in Early Childhood: a Syndrome Caused by Contaminated Environment

1984 • 76 citations

Typhoid vaccines come of age

1989 • 76 citations

Molecular and Cellular Biology of Shigella flexneri Invasiveness: From Cell Assay Systems to Shigellosis

1992 • 76 citations

Investigational Vaccine forEscherichia coliO157: Phase 1 Study of O157 O‐SpecificPolysaccharide‐Pseudomonas aeruginosaRecombinant Exoprotein A Conjugates in Adults

1998 • 75 citations

Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis

1965 • 74 citations

Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates

1995 • 74 citations

Vaccines againstCampylobacter jejuni

1997 • 73 citations

Biotype as determinant of natural immunising effect of cholera

1991 • 73 citations

An oral B subunit: whole cell vaccine against cholera

1992 • 72 citations

Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers

1987 • 72 citations

Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli

1996 • 72 citations

Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine

1994 • 72 citations

Production of IFN-γ and IL-10 to Shigella Invasins by Mononuclear Cells from Volunteers Orally Inoculated with a Shiga Toxin-Deleted Shigella dysenteriae Type 1 Strain

2000 • 68 citations

A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.

1998 • 66 citations

Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains

1997 • 65 citations

Synergism between Ecologic and Immunologic Control Mechanisms of Intestinal Flora

1974 • 65 citations

Non-replicating oral whole cell vaccine protective against enterotoxigenicEscherichia coli(ETEC) diarrhea: Stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes

1988 • 65 citations

Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine

1996 • 65 citations

Diarrheal Disease among Military Personnel During Operation Restore Hope, Somalia, 1992–1993

1995 • 65 citations

The Human Humoral Immune Response to Salmonella typhi Ty2la

1991 • 63 citations

Oral Poliovirus Vaccine

1965 • 63 citations

Enteric infections

1990 • 62 citations

Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR

1996 • 61 citations

Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori

1999 • 60 citations

Constitutive Expression of the Vi Polysaccharide Capsular Antigen in AttenuatedSalmonella entericaSerovar Typhi Oral Vaccine Strain CVD 909

2000 • 59 citations

The Carrier State in Muscular Dystrophy of the Duchenne Type

1965 • 58 citations

Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O

1995 • 58 citations

Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers

1995 • 57 citations

Attenuated Shigella flexneri 2a Vaccine Strain CVD 1204 Expressing Colonization Factor Antigen I and Mutant Heat-Labile Enterotoxin of Enterotoxigenic Escherichia coli

2000 • 57 citations

Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults

1989 • 56 citations

Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology

1985 • 56 citations

Asymptomatic environmental enteropathy among slum-dwelling infants.

1994 • 52 citations

Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru

1997 • 52 citations

Construction of genetically markedVibrio choleraeO1 vaccine strains

1993 • 52 citations

Analysis of antigenic determinants in cholera enterotoxin and heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli

1983 • 50 citations

Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by ΔaroC, ΔaroD Salmonella typhi vaccine strain CVD 908

1995 • 49 citations

Recombinant Salmonella vectors in vaccine development.

1994 • 47 citations

Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera

1991 • 47 citations

Live oral cholera vaccine : from principle to product

1995 • 46 citations

VIREMIA IN INFANTS VACCINATED WITH ORAL POLIOVIRUS VACCINE (SABIN)1*

1964 • 44 citations

IMMUNISATION OF VOLUNTEERS WITH A SYNTHETIC PEPTIDE VACCINE FOR ENTEROTOXIGENIC ESCHERICHIA COLI

1986 • 43 citations

Characterization of phenotypic, serological, and toxigenic traits of Vibrio cholerae O139 bengal

1994 • 42 citations

Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O

1995 • 42 citations

Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults

1995 • 41 citations

Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier

1996 • 39 citations

Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.

1974 • 38 citations

Microbial-Host Interactions at Mucosal Sites. Host Response to Pathogenic Bacteria at Mucosal Sites

1999 • 38 citations

Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers

1999 • 37 citations

SHIGELLOSIS IN CUSTODIAL INSTITUTIONS1

1972 • 34 citations

Epidemiology of Small Bowel Bacterial Overgrowth and Rice Carbohydrate Malabsorption in Burmese (Myanmar) Village Children

1992 • 34 citations

Shigellosis in custodial institutions

1974 • 34 citations

Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.

1997 • 33 citations

Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine.

1989 • 32 citations

Attaching and effacing of host cells by enteropathogenicEscherichia coliin the absence of detectable tyrosine kinase mediated signal transduction

1996 • 31 citations

Monoclonal antibodies with an expanded repertoire of specificities and potent neutralizing activity for Escherichia coli heat-labile enterotoxin

1984 • 31 citations

Shigellosis in Custodial Institutions. IV. In Vivo Stability and Transmissibility of Oral Attenuated Streptomycin-Dependent Shigella Vaccines

1975 • 29 citations

Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines

1996 • 28 citations

Safety and Immunogenicity of Salmonella typhi Ty21a Liquid Formulation Vaccine in 4- to 6-Year-Old Thai Children

1992 • 26 citations

SHIGELLOSIS IN CUSTODIAL INSTITUTIONS

1976 • 23 citations

Enhancement of anti-Shigella lipopolysaccharide (LPS) response by addition of the cholera toxin B subunit to oral and intranasal proteosome-Shigella flexneri 2a LPS vaccines

1994 • 22 citations

Further Observations on the Properties of the Vi Antigen of B. typhosus and its Corresponding Antibody

1935 • 19 citations

Immunogenicity of IpaC-Hybrid Proteins Expressed in theShigella flexneri2a Vaccine Candidate SC602

1998 • 18 citations

[Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults].

1993 • 17 citations

Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid

1994 • 16 citations

Regulatory Considerations forCampylobacterVaccine Development

1997 • 15 citations

Sociodemographic Factors Associated with Serum Anti-Shigella Lipopolysaccharide Antibodies and Shigellosis

1991 • 14 citations

Deleted Work

1955 • 0 citations